Skip to main content
10654 Suchergebnisse für:

Cardiogenic Shock 

sortieren nach |
"Aktualität" sortiert die Ergebnisse nach Publikationsdatum. "Relevanz" berücksichtigt auch noch andere Faktoren wie zum Beispiel die Häufigkeit der Suchbegriffe im Text.
  1. Open Access 01.12.2024 | ReviewPaper

    Management of cardiogenic shock: a narrative review

    Cardiogenic shock (CS) is characterized by low cardiac output and sustained tissue hypoperfusion that may result in end-organ dysfunction and death. CS is associated with high short-term mortality, and its management remains challenging despite …

  2. 18.03.2024 | BriefCommunication

    What’s new in VA-ECMO for acute myocardial infarction-related cardiogenic shock

  3. Open Access 01.12.2024 | OriginalPaper

    The management of heart failure cardiogenic shock: an international RAND appropriateness panel

    Cardiogenic shock (CS) represents the final common pathway by which cardiovascular disease causes end-organ dysfunction through sustained hypoperfusion and tissue dysoxia [ 1 ]. As a clinical syndrome, CS exhibits heterogeneity with respect to its …

  4. Open Access 01.12.2024 | OriginalPaper

    Oxygenation management during veno-arterial ECMO support for cardiogenic shock: a multicentric retrospective cohort study

    While Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) is primarily used to restore adequate tissue perfusion by increasing systemic blood flow, it also significantly impacts blood oxygenation because of the oxygenator integrated into …

  5. Open Access 01.12.2024 | Letter

    Scrutinizing mechanical circulatory support in cardiogenic shock: Have we jumped the gun?

    Despite increasing therapeutic options and disposable resources, cardiogenic shock (CS) remains a formidable condition with high mortality. Today, veno-arterial extracorporeal membrane oxygenation and microaxial flow devices (Impella, Abiomed …

  6. 10.01.2024 | OriginalPaper

    Cardiogenic shock in a 28-year-old woman associated with sibutramine use

    A 28-year-old woman collapsed in her home, and her companion rushed to call emergency services. Upon arrival, a physician performed CPR and endotracheal intubation, successfully restoring her voluntary heart rhythm. However, while en route to the …

  7. Open Access 01.12.2024 | OriginalPaper

    Left atrial myxoma with cardiogenic shock following a myocardial infarction: a case report

    Myxomas are the most common primary cardiac tumor [ 1 ]. More than 70% of all cardiac myxomas originate from the left atrium and 18% from the right atrium [ 2 ]. Most myxomas present with either manifestations of embolic or obstructive …

  8. Open Access 01.12.2024 | OriginalPaper

    Association between intensive care unit nursing grade and mortality in patients with cardiogenic shock and its cost-effectiveness

    Cardiogenic shock (CS) is defined as reduced cardiac output together with the impairment of multi-organ blood flow and oxygen delivery to meet metabolic demands [ 1 , 2 ]. Although the widespread adoption of early revascularization strategies and …

  9. Open Access 14.02.2024 | OriginalPaper

    Sex-related differences in patients presenting with heart failure–related cardiogenic shock

    Heart failure–related cardiogenic shock (HF-CS) is a severe condition characterized by acute deterioration in cardiac output that results in a life-threatening hypoperfusion of end-organs. This condition can be caused by a variety of …

  10. Open Access 01.12.2024 | Letter

    Cardiogenic shock: all hail the RCT, long live the registry

  11. Open Access 01.12.2024 | OriginalPaper

    Diaphragm thickness modifications and associated factors during VA-ECMO for a cardiogenic shock: a cohort study

    Cardiogenic shock often necessitates mechanical ventilation due to accompanying acute respiratory failure [ 1 , 2 ]. Heart failure has been demonstrated to be linked to diaphragm weakness in non-critically ill patients [ 3 – 7 ]. The diaphragm, as …

  12. 04.03.2024 | OriginalPaper

    Venoarterial extracorporeal membrane oxygenation in immunocompromised patients with cardiogenic shock: a cohort study and propensity-weighted analysis

    Cardiogenic shock remains associated with high hospital mortality, reaching 58% in a comprehensive international registry of 9,025 adult patients treated with extracorporeal membrane oxygenation (ECMO) [ 1 ]. However, advancements in temporary …

  13. Open Access 01.12.2024 | OriginalPaper

    Serial daily lactate levels association with 30-day outcome in cardiogenic shock patients treated with VA-ECMO: a post-hoc analysis of the HYPO-ECMO study

    The interpretation of lactate levels and their changes over time in circulatory shock is intricate, involving assessments of both production and clearance. Lactate in shock primarily originates from two processes: pure anaerobic metabolism, which …

  14. 20.12.2023 | ReviewPaper

    Goal-Directed Therapy in Cardiogenic Shock: No Magical Recipe

    Cardiogenic shock (CS) is a critical condition associated with high mortality, and survival rates have scarcely improved over the past decades [ 1 ]. Goal-directed therapy (GDT) was initially suggested for the early management of septic shock

  15. Open Access 01.12.2024 | OriginalPaper

    Single arterial access technique for simultaneous dual mechanical circulatory support in cardiogenic shock

    Temporary mechanical circulatory support is a treatment of choice for patients in severe cardiogenic shock. Combining veno-arterial extracorporeal life support (ECLS) with devices that enable left ventricular unloading emerges as a promising …

  16. Open Access 20.11.2023 | OriginalPaper

    Association of systemic inflammation with shock severity, 30-day mortality, and therapy response in patients with cardiogenic shock

    Cardiogenic shock (CS) remains a clinical challenge with a high mortality despite significant advances in overall cardiovascular medicine [ 1 , 2 ]. The high mortality of CS likely reflects its complex and incompletely understood pathophysiology …

  17. 11.01.2024 | ReviewPaper

    Mechanical circulatory support for cardiogenic shock: a network meta-analysis of randomized controlled trials and propensity score-matched studies

    Cardiogenic shock accounts for up to 5% of acute heart failure presentations and around 14–16% of patients reported in cardiac intensive care datasets [ 1 , 2 ]. It complicates up to 15% of all myocardial infarctions, and is the leading cause of …

  18. Open Access 20.11.2023 | OriginalPaper

    Association between left ventricular ejection fraction, mortality and use of mechanical circulatory support in patients with non-ischaemic cardiogenic shock

    Cardiogenic shock (CS) is a serious pathological condition with acute deterioration of cardiac output, leading to life-threatening hypo-perfusion of end-organs, and can be caused by a wide range of cardiovascular diseases [ 1 – 3 ]. In the last …

  19. Open Access 23.01.2024 | OriginalPaper

    Discussion of hemodynamic optimization strategies and the canonical understanding of hemodynamics during biventricular mechanical support in cardiogenic shock: does the flow balance make the difference?

    Cardiogenic shock (CS) is a condition of severe myocardial and circulatory failure. To stabilize hemodynamics in CS, extracorporeal mechanical circulatory support (MCS), i.e., veno-arterial membrane oxygenation (VA-ECMO) and Impella (Abiomed …

  20. 24.02.2024 | Online First

    Utilizing extracorporeal life support in patients with cardiogenic shock related to acute myocardial infarction: a critical appraisal of the current evidence

    Cardiogenic shock (CS) is a potential complication of acute myocardial infarction (MI) in 10% of inpatients and 30-day mortality can be as high as 50% in these patients [ 1 ]. While timely cardiovascular lesion treatment via revascularization …

Suchergebnisse filtern:

Suchoperatoren:

„ ... ... “ Findet Dokumente mit genau dieser Wortgruppe in exakt dieser Schreibweise und Reihenfolge (z.B., "rheumatische Beschwerden").
AND / UND Findet Dokumente, in denen beide Begriffe zusammen vorkommen (z.B., alkohol UND demenz).
OR / ODER Findet Dokumente, in denen einer der beiden oder beide Begriffe vorkommen (z.B., hiv ODER aids).
Leerzeichen Findet Dokumente, in denen alle Begriffe vorkommen. Der Leerschritt wird als UND interpretiert (z.B., isolierte systolische hypertonie).
NOT / NICHT Findet Dokumente, in denen der Begriff nach NOT nicht vorkommt (z.B., sars NOT sars-cov-2).
COUNT(...)>n Findet Dokumente, in denen der gesuchte Begriff mehr als n mal vorkommt. n steht für eine beliebige Anzahl (z.B., COUNT(mammakarzinom)>8).
NEAR(..., ..., ) Findet Dokumente, in denen beide Begriffe in beliebiger Reihenfolge innerhalb von maximal n Worten zueinander stehen. Empfehlung: wählen Sie zwischen 15 und 30 als maximale Wortanzahl (z.B., NEAR(covid, diabetes,20)).
* Findet Dokumente, in denen der Begriff in Wortvarianten vorkommt, wobei diese VOR, HINTER oder VOR und HINTER dem Suchbegriff anschließen können (z.B., thrombose*, *thrombose, *thrombose*).
? Findet Dokumente mit dem Suchbegriff in verschiedenen Schreibweisen, hier mit s oder z, also organisation und organization. Das ? steht für eine einzige Stelle (z.B., organi?ation).
& + - Sonderzeichen werden als UND interpretiert (z.B., Diagnose + Therapie).

Sie können Operatoren mit Ihrer Suchanfrage kombinieren, um diese noch präziser einzugrenzen.

Fahren Sie mit der Maus über den Suchoperator, um eine Erklärung seiner Funktionsweise anzuzeigen.